Ovarian Cancer

>

Latest News

Image of icons representing different organs in a circle with the female reproductive system in the middle under a magnifying glass
Relacorilant Combo Sustains Ovarian Cancer Benefit Post Platinum Break

June 23rd 2025

The combination of relacorilant and nab-paclitaxel improved survival in platinum-resistant ovarian cancer following a break from platinum-based chemo.

Image of a person holding a model of the female reproductive system
Relacorilant Combo Boosts PFS in Resistant Ovarian Cancer

June 13th 2025

Photo of the FDA's building and sign
May FDA Approvals in Oncology: Firsts in PPGL, Anal Cancer, and More

June 6th 2025

Graphic of the female reproductive system
Pembrolizumab Combo Improves PFS in Platinum-Resistant Ovarian Cancer

May 21st 2025

Graphic reading "FDA Approved" resembling a stamp mark
Avutometinib/Defactinib Earns FDA Accelerated Approval for KRAS+ LGSOC

May 8th 2025

Video Interviews

More News